Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil D Gross

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 7, 2024
Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areasAmanda-Louise Fenger Carlander, Simone Kloch Bendtsen, Jacob H Rasmussen, et al.
Thyroid : Official Journal of the American Thyroid Association|August 25, 2018
Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth EditionsSamantha Tam, Mongkol Boonsripitayanon, Moran Amit, et al.
JAMA Oncology|August 8, 2020
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019Anastasios Maniakas, Ramona Dadu, Naifa L Busaidy, et al.
JCO Precision Oncology|August 17, 2022
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid CarcinomaJennifer Rui Wang, Matthew Montierth, Li Xu, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 27, 2019
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal CancerKatherine A Hutcheson, Carla L Warneke, Christopher M K L Yao, et al.
Cancer|September 15, 2020
Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer CenterStefanos Boukovalas, Ryan P Goepfert, J Michael Smith, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 6, 2019
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and NeckSamantha Tam, Christopher M K L Yao, Moran Amit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancerNeil D Gross, Julie E Bauman, William E Gooding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)Robert L Ferris, Yael Flamand, Gregory S Weinstein, et al.
Current Treatment Options in Oncology|June 4, 2021
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification StrategyNicolette Taku, Li Wang, Adam S Garden, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|March 7, 2024
Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areasAmanda-Louise Fenger Carlander, Simone Kloch Bendtsen, Jacob H Rasmussen, et al.
Thyroid : Official Journal of the American Thyroid Association|August 25, 2018
Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth EditionsSamantha Tam, Mongkol Boonsripitayanon, Moran Amit, et al.
JAMA Oncology|August 8, 2020
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019Anastasios Maniakas, Ramona Dadu, Naifa L Busaidy, et al.
JCO Precision Oncology|August 17, 2022
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid CarcinomaJennifer Rui Wang, Matthew Montierth, Li Xu, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 27, 2019
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal CancerKatherine A Hutcheson, Carla L Warneke, Christopher M K L Yao, et al.
Cancer|September 15, 2020
Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer CenterStefanos Boukovalas, Ryan P Goepfert, J Michael Smith, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 6, 2019
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and NeckSamantha Tam, Christopher M K L Yao, Moran Amit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancerNeil D Gross, Julie E Bauman, William E Gooding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)Robert L Ferris, Yael Flamand, Gregory S Weinstein, et al.
Current Treatment Options in Oncology|June 4, 2021
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification StrategyNicolette Taku, Li Wang, Adam S Garden, et al.
Pageof 14